AyushNet
Polyherbal formulations for gastrointestinal disorders
Article

Polyherbal formulations for gastrointestinal disorders

Introduction

Gastrointestinal (GIT) disorders such as dyspepsia, gastritis, gastroesophageal reflux disease (GERD), constipation, diarrhea, peptic ulcer disease, and irritable bowel syndrome (IBS) are highly prevalent and significantly impact quality of life. Although conventional therapies provide symptomatic relief, concerns regarding long-term adverse effects, recurrence, and incomplete symptom control have stimulated interest in traditional herbal therapies.1

Ayurveda employs polyherbal formulations that combine multiple medicinal plants to achieve synergistic therapeutic effects. These formulations are designed to restore digestive balance, improve gut function, and address the underlying causes of disease. Recent pharmacological and clinical studies have increasingly supported the efficacy of several Ayurvedic preparations in managing a broad spectrum of gastrointestinal disorders.2

Major polyherbal formulations used in GIT disorders

Triphala:

  • Triphala is among the most extensively studied Ayurvedic formulations and consists of three fruits: Emblica officinalis (Amla), Terminalia chebula (Haritaki), and Terminalia bellirica (Bibhitaki).
  • Traditionally regarded as a Tridosha-balancing remedy, Triphala promotes digestive health, enhances bowel regularity, and acts as a gentle laxative.
  • Rich in tannins, flavonoids, and vitamin C, it exhibits potent antioxidant, antimicrobial, and gastroprotective properties.
  • Clinical studies have demonstrated benefits in constipation, functional dyspepsia, and as an adjunctive therapy in peptic ulcer disease. Additionally, Triphala has been shown to support gut microbial balance and improve overall gastrointestinal function.

Avipattikar Churna:

  • Avipattikar Churna is a classical formulation containing Triphala, Trikatu (ginger, black pepper, and long pepper), and several additional digestive herbs.
  • It is traditionally prescribed for disorders associated with aggravated Pitta dosha, including hyperacidity, gastritis, acid reflux, and indigestion.
  • Experimental and clinical studies suggest that the formulation possesses anti-ulcer, carminative, and digestive-stimulant properties. Its ability to reduce gastric acidity, improve digestion, and minimize ulcer recurrence makes it a valuable option in upper gastrointestinal disorders.

Kutajarishta:

  • Kutajarishta is a fermented herbal preparation primarily based on Holarrhena antidysenterica (Kutaj). It has long been used for chronic diarrhea, dysentery, and gastrointestinal infections.
  • Research indicates that Kutajarishta exerts antidiarrheal, antimicrobial, and immunomodulatory effects.
  • Clinical studies have reported significant reductions in stool frequency, severity, and duration in both acute and chronic diarrheal conditions, supporting its role in intestinal health and infection control.

Other Ayurvedic therapies:

Additional Ayurvedic interventions include formulations such as Dhatri Lauha, which is beneficial in digestive disorders associated with iron deficiency and anemia. Panchakarma therapies, particularly Basti (medicated enema), are often recommended for Vata-related constipation and bowel dysfunction. These therapies aim to restore digestive equilibrium, improve intestinal motility, and support overall gastrointestinal well-being.

Mechanisms underlying therapeutic effects

Polyherbal formulations exert their benefits through multiple complementary mechanisms. Many Ayurvedic herbs possess anti-inflammatory properties by modulating cyclooxygenase (COX) and lipoxygenase (LOX) pathways, thereby reducing gastrointestinal inflammation and mucosal injury. Their antioxidant constituents, including flavonoids, tannins, and phenolic compounds, help neutralize free radicals and protect the gastric and intestinal mucosa from oxidative stress.

Several formulations also demonstrate antimicrobial activity against pathogenic bacteria, fungi, and protozoa implicated in gastrointestinal infections. Gastroprotective actions are achieved through enhanced mucus production, strengthening of the mucosal barrier, and regulation of gastric acid secretion. Furthermore, herbs such as ginger and psyllium (Plantago ovata) help normalize intestinal motility, improving bowel function in both constipation and diarrhea.

Clinical evidence and safety considerations

Clinical evidence supports the use of Triphala for constipation and functional dyspepsia, Avipattikar Churna for acid-related disorders, Kutajarishta for diarrhea and dysentery, and liquorice-containing formulations for gastritis and peptic ulcers. Bael-based preparations have also demonstrated antidiarrheal and gastroprotective benefits.

Although Ayurvedic formulations are generally considered safe when used appropriately, safety concerns remain important. Prolonged high-dose use of liquorice may cause hypertension, fluid retention, and hypokalemia. Excessive consumption of Aloe vera may result in diarrhea, abdominal cramps, and electrolyte disturbances. Polyherbal products may also carry risks related to contamination, adulteration, and herb–drug interactions, emphasizing the need for standardized manufacturing practices and professional supervision.

Conclusion

Ayurvedic polyherbal formulations offer a comprehensive and multi-targeted approach to the management of gastrointestinal disorders. Preparations such as Triphala, Avipattikar Churna, and Kutajarishta have demonstrated beneficial effects through anti-inflammatory, antioxidant, antimicrobial, gastroprotective, and bowel-regulating mechanisms. While current evidence supports their therapeutic potential in conditions such as dyspepsia, gastritis, GERD, constipation, diarrhea, and IBS, greater emphasis on standardization, quality control, and rigorous clinical evaluation is needed. Future integration of evidence-based Ayurvedic therapies with conventional gastroenterology may provide a more holistic, safe, and patient-centered approach to digestive health.3

 

References:

  1. Jablonska B, Mrowiec S. Gastrointestinal Disease: New Diagnostic and Therapeutic Approaches. Biomedicines. 2023;11(5):1420. Published 2023 May 11. doi:10.3390/biomedicines11051420 https://pmc.ncbi.nlm.nih.gov/articles/PMC10216256/
  2. Czigle S, Bittner Fialova S, Toth J, Mucaji P, Nagy M, On Behalf Of The Oemonom. Treatment of Gastrointestinal Disorders-Plants and Potential Mechanisms of Action of Their Constituents. Molecules. 2022;27(9):2881. Published 2022 Apr 30. doi:10.3390/molecules27092881 https://pmc.ncbi.nlm.nih.gov/articles/PMC9105531/
  3. Wankhade MP, Dahapute A, Pawsale AA, Thombal PU, Asolkar PD, Jawanjal GS, et al. A comprehensive review on Ayurvedic herbs in the management of gastrointestinal tract (GIT) disorders. Int J Sci Res Technol. 2026;4(06):198-205. https://www.ijsrtjournal.com/article/a-comprehensive-review-on-ayurvedic-herbs-in-the-management-of-gastrointestinal-tract-git-disorders